StockData
Apimeds Pharmaceuticals US, Inc. logo

Apimeds Pharmaceuticals US, Inc. (APUS) stock

APUSNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$1.89−0.06 (-3.08%)

Close on Nov 18, 2026Market cap $2.85MP/E –Yield –

Apimeds Pharmaceuticals US price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Apimeds Pharmaceuticals US's price to book ratio was 0.0× on Nov 11, 2026, against 4.5× a year earlier.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.0×−2.5
2025Dec 31, 20252.5×–

More Apimeds Pharmaceuticals US figures

See a number that looks wrong?